GlucoTrack Inc Market Cap ($391.09K)
Market Cap & Net Worth: GlucoTrack Inc (GCTK)
GlucoTrack Inc market cap. GlucoTrack Inc (NASDAQ:GCTK) has a market capitalization of $391.09K ($391.09K) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31162 globally and #6325 in its home market, demonstrating a 21.53% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GlucoTrack Inc's stock price $0.49 by its total outstanding shares 798144 (798.14K). Also see how efficiently does GlucoTrack Inc generate cash for how efficiently the company converts equity into cash flow.
GlucoTrack Inc Market Cap History (2015–2026)
GlucoTrack Inc market cap history from 2015 to 2026. Data shows change from $181.58 Million to $391.09K (-44.47% CAGR). Check GlucoTrack Inc (GCTK) stock price for real-time trading data and today's change.
Index Memberships
GlucoTrack Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.00% | #915 of 976 |
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #2886 of 3165 |
Weight: GlucoTrack Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
GlucoTrack Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GlucoTrack Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is GlucoTrack Inc growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
260.21x
GlucoTrack Inc's market cap is 260.21 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $129.70 Million | $611.69K | -$5.41 Million | 212.03x | N/A |
| 2017 | $103.76 Million | $589.46K | -$10.33 Million | 176.02x | N/A |
| 2018 | $25.94 Million | $43.49K | -$6.72 Million | 596.48x | N/A |
| 2019 | $31.13 Million | $208.00K | -$3.52 Million | 149.65x | N/A |
| 2020 | $18.42 Million | $70.78K | -$2.70 Million | 260.21x | N/A |
Competitor Companies of GCTK by Market Capitalization
Companies near GlucoTrack Inc in the global market cap rankings as of November 3, 2026. Also see total assets of GlucoTrack Inc for a full breakdown of the balance sheet.
Key companies related to GlucoTrack Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of GlucoTrack Inc (2015–2026)
Market capitalization of GlucoTrack Inc from 2015 to today. Between 2015 and today, GlucoTrack Inc's market cap moved from $181.58 Million to $ 391.09K, with a yearly change of -44.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $391.09K | -87.34% |
| 2025 | $3.09 Million | +937.53% |
| 2024 | $297.71K | -71.53% |
| 2023 | $1.05 Million | -81.42% |
| 2022 | $5.63 Million | -66.19% |
| 2021 | $16.64 Million | -9.64% |
| 2020 | $18.42 Million | -40.83% |
| 2019 | $31.13 Million | +20.00% |
| 2018 | $25.94 Million | -75.00% |
| 2017 | $103.76 Million | -20.00% |
| 2016 | $129.70 Million | -28.57% |
| 2015 | $181.58 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of GlucoTrack Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $391.09K USD |
| MoneyControl | $391.09K USD |
| MarketWatch | $391.09K USD |
| marketcap.company | $391.09K USD |
| Reuters | $391.09K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GlucoTrack Inc
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications… Read more